In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

sphingotec GmbH

www.sphingotec.de/en

Latest From sphingotec GmbH

Wellington Partners Unveils €210m Eurocentric Biotech/Medtech Fund WPLS-V

With its WPLS-IV fund now fully committed, Wellington Partners has returned to the market and raised €210m in its WPLS-V fund which will focus on European biotech and medtech opportunities.

Financing StartUps and SMEs

Medical Device Deals Update, November-December 2014

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Medical Device Deals Update column is a survey of recent medtech M&A, alliance, and financing activity. This month’s column covers deals announced October-November 2014.

Medical Device

Deals Shaping The Medical Industry, November 2014

BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Biotechnology
  • In Vitro Diagnostics
    • Chemistry, Immunoassay
  • Therapeutic Areas
  • Cardiovascular
  • Infectious & Viral Diseases
  • Renal System
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Germany
  • Parent & Subsidiaries
  • sphingotec GmbH
  • Senior Management
  • Andreas Bergmann, PhD, CEO
  • Contact Info
  • sphingotec GmbH
    Phone: 3302 20 56 5 0
    Neuendorfstr. 15 A
    Hennigsdorf, 16761
    Germany
Advertisement
Advertisement
UsernamePublicRestriction

Register